Maze Dive DIVE Nº 014

ASP Isotopes (JSE: ISO): (JSE: ISO): The Pretoria Isotope Play Lists

Length: 9 min

Loads the Spotify player. Spotify sets its own cookies.

ASP Isotopes (JSE: ISO) listed on the JSE on 27 August 2025 with Nasdaq roots and Pretoria plants. What it does, why it listed here, and the real risks.

Show notes

It isn’t a new tequila and you definitely can’t braai with it. ASP Isotopes makes enriched isotopes for medicine, chips and nuclear energy, mostly from Pretoria, and it just added a JSE listing to its Nasdaq one. Science fiction meets Sandton, with a Pretoria accent.

By The Money Maze | Listen to the episode: Spotify

New listings on the JSE are rarer than a quiet taxi rank, so when one arrives with lab coats instead of hard hats, people notice.

On Wednesday 27 August 2025, ASP Isotopes started trading on the JSE Main Board under the share code ISO. The JSE said it was the third new listing of 2025, taking the exchange to 276 listed companies.

What does ASP Isotopes do?

Isotopes are versions of the same chemical element with slightly different weights. Some of them are very useful, and very hard to separate. ASP Isotopes enriches them: it concentrates the useful version so industry can use it.

It uses two technologies. Its own Aerodynamic Separation Process, ASP, for lighter elements, and a Quantum Enrichment technology it’s developing, aimed partly at nuclear energy. The focus areas:

  • Healthcare: isotopes such as carbon-14 for drug development, and ytterbium-176, which is used to make a cancer treatment isotope.
  • Semiconductors and quantum computing: silicon-28, prized for next-generation chips.
  • Nuclear energy: enriched fuels for future reactors.

Not products you’ll find at Checkers. Essential ingredients for some of the most advanced industries on earth.

The Pretoria connection

Here’s the local angle. ASP Isotopes is a US-registered company with its primary listing on the Nasdaq, but its three enrichment facilities are in Pretoria. Its pre-listing statement said it had finished commissioning and was starting commercial production at its carbon-14 and silicon-28 plants, and producing commercial samples of highly enriched ytterbium-176.

So while American investors see a futuristic isotope stock, South Africans can point to plants down the road and say, “That’s ours.”

Secondary listing explained

ASP’s JSE listing is a secondary, or inward, listing. The primary listing stays on the Nasdaq, and the number of shares in issue doesn’t change. It was done by introduction, which means no new money was raised. 91,413,109 shares were listed on the JSE, classified under speciality chemicals.

Why bother? Two reasons. First, access: South Africans can buy it in rands, without opening an offshore account. Second, a deal: ASP was buying Renergen, the JSE-listed helium and gas company, and the pre-listing statement said the JSE listing was in anticipation of that scheme, so ASP shares listed here could be used to pay Renergen shareholders.

How dual-listed shares behave

We’ve seen plenty of companies listed in two places: Prosus in Amsterdam and Johannesburg, Anglo American in London and Johannesburg. Usually the primary market drives the price and the secondary market follows, because arbitrage traders step in when prices drift apart.

But early days can be messy. On debut, Business Report noted the JSE price was trading at an 18% premium to the previous Nasdaq close, with thin volumes and clear demand. In the days that followed, the JSE shares ran much higher, which is what the episode title is about. When local investors are starved of exciting new stocks and only a small number of shares sit on the JSE register, prices can sprint well ahead of the main market. That’s a liquidity effect, not a sudden discovery of hidden value, and it tends to correct.

ASP Isotopes bull case

One share with exposure to healthcare, semiconductors and nuclear energy. Proprietary technology, built and run largely in South Africa. Plants already in commissioning and early production rather than just PowerPoints. Plans for more enrichment facilities in South Africa and elsewhere. And the JSE gets a rare, genuinely different listing.

ASP Isotopes bear case

It describes itself as a development-stage company. Scaling isotope production is expensive and slow, and cash burn is real. If funding dries up, progress slows. Customers and contracts still need to prove the market is big enough. The share has been extremely volatile on the Nasdaq, and a thinly traded secondary listing can swing even harder. Exciting, yes. Safe, no.

What to watch

  • Cash burn versus revenue as production ramps up.
  • Whether silicon-28 and ytterbium-176 turn into steady commercial sales.
  • New isotopes and new plants arriving on schedule.
  • The gap between the JSE and Nasdaq prices, which tells you whether the local hype has cooled.

Stokvel Starter Pack

  • Secondary listing: an extra listing on another exchange. The primary market still leads.
  • Listing by introduction: shares listed without raising new money.
  • Isotope enrichment: concentrating the useful version of an element.
  • Arbitrage: traders buying in the cheap market and selling in the expensive one, which pulls prices together.
  • Development-stage company: still building the business. Expect volatility and capital raises.

Takeaway: A JSE listing gives South Africans easy access to a homegrown science story. It doesn’t make the science easier. Don’t bet the boerie money on first-week fireworks.

Want the full braai version? Listen on Spotify. And if you’d like the Maze in your inbox, join the free Maze Mail list.

More from The Money Maze

Sources

  1. JSE welcomes ASP Isotopes secondary listing, JSE, 27 Aug 2025.
  2. Abridged pre-listing statement, ASP Isotopes on SENS, 8 Aug 2025.
  3. ASP Isotopes announces expected commencement of dual listing on the JSE, ASP Isotopes, 8 Aug 2025.
  4. ASP Isotopes lists on the JSE as its South African expansion continues, Business Report, 27 Aug 2025.

This is not financial advice.

Transcript

Read the full transcript

Auto-generated transcript, may contain errors.

Download as plain text (7 KB)

0:00 Come to your Sunday morning maze dive. This is the Sunday morning segment of the Money Maze where we take a deep dive into a single JSE listed stock making the headlines for the last week. I'm your host, Jay, and today we're talking about the latest company to join the JSE, ASP Isotopes. Now don't get confused, this isn't a new tequila brand and you definitely can't pry with it. This company plays in the nuclear, semiconductor and medical space, and they've just made their dual listing debut on the Johannesburg Stock Exchange.

0:33 It's science fiction meeting Santon with a Pretoria accent. O. Let's look at the big headline number. ASP Isotopes hit the JSC boards on the 27th of August under the ticker ISO. They listed 91,413,109 ordinary shares. Each was a par value of 1 US cent. That's the exact same structure as the NASDAQ listing in the US.

0:59 This is the third new listing on the JSE 2025, bringing the JSE to 276 companies worth a combined 22.47 trillion Rand. That's trillion with 80 enough to fix all the potholes in halting and still have cash left over to sponsor Kaizer Chiefs striker can actually score. So who is ASP isotopes? It's not your typical JSIN newcomer.

1:24 They don't dig holes in the ground and they don't hand out home loans. They enrich isotopes, specialised versions of chemical elements that industries around the world need their secret sources, something called quantum enrichment technology, which promises to be faster, cheaper and more accurate than traditional methods. Think of it as isotope enrichment. 2.0.

1:47 They focus on three industries, healthcare isotopes for cancer treatment and medical imaging, semiconductors and quantum computing, where silicon 28 is key for powering the next generation of chips. Nuclear energy isotopes that improve fuel and reactor efficiency would definitely not product you'll find checkers, but essential ingredients in the world's most advanced industries, the South African roots and the NASDAQ passport. So here's the thing, the part that matters for us. IASP may be listed in New York, but it's a South African story. They've got 3 facilities in Pretoria and 97% of their workforce is South Africa.

2:28 So while American investors see them as a futuristic isotope play, we can point to factories down the road and say that's ours. Will this jazz listing locals can finally buy into the company without having to open offshore accounts or mess around with dollars. It's like rugby. NASDAQ is Twickenham, but the Jsc's Loftus. Both matter, but only one comes with Bry placing clippies and coke at half time.

2:53 These guys aren't just selling promises, they're already producing Silicon 28. Commercial production kicked off in March 2025 and they've shipped samples to US customers on NASDAQ. That milestone gave the sheer and nice bump on the JSE. It meant they arrived with proof, not just PowerPoints by Terbium 176. I'm having a pronounced that correctly.

3:14 Production started in April, enrichment reached 92.4% and the goal is nearly 99.8%. The first samples were lined up for delivery right around the Jay-Z debut pipeline. They've got Nickel 64, Catalonian 160 and Zinc 68 all lined up next with equipment permits already secured. In simple terms, they aren't just pitching the future, they shipping product today. So why bother listing here if they're already on the NASDAQ? Well, on NASDAQ, ISP has access to global liquidity Panic with speculative science plays often get more generous valuations. It's the big show where biotech and nuclear startup's rub shoulders with Silicon Valley darlings on the jazz ASP gets homefield advantage.

4:01 Local investors can finally back a company that employs their neighbors and runs plants in Pretoria. Plus, the JSE desperately needs fresh listings, and this one adds a little sparkle. On NASDAQ. I use one of hundreds of futuristic plays. The JSC stands out like Blvd. at a vegan picnic. Now here's where things got wild. ISO debuted at around 217 Rand per share on the 27th of August.

4:27 Within just a few trading sessions, by the start of September was already closing around 1100 Rand. That's a 400% surge quicker than job taxi waving with peak hour traffic. So why the fireworks? Well, two reasons. First, South African investors are starved for new exciting stocks. Let's be honest, another miner Will Bank doesn't really get the Pulse Racing Pretoria based Isotope Company, though.

4:52 That's different. Second, liquidity. The joyous listing doesn't have as many shares floating around as NASDAQ, so when buyers pile in, prices rocket faster than a vuvuzela crissinger at a soccer set match. As always, things can go up and they can come down early. Post listing Spike often settle back when their dust clears the keys where the ASP can keep delivering milestones that justify the hype. So how dual listings usually play out? ASP isn't the first to try and do list. We've seen it was process in Amsterdam and Johannesburg, Anglo in London and Johannesburg and plenty more. In most cases, the primary listing, whether it's London or Amsterdam, drives the price or the secondary listing follows. That means Iso's JSE price will likely track their NASDAQ price overtime because arbitrage traders step in to smooth out the big gaps.

5:48 So if it rockets in New York, you'll see it here. If it tanks in the US, expect the same in Santan. The real benefit of the Jaish enlisting is access. It allows S Africans to buy a slice of NASDAQ style science without leaving home. So why does this matter for investors? Let's ask, what's in it for you? The good news one stocks give you exposure to healthcare, semiconductors and nuclear energy.

6:14 Its global but 97% local and the JC gets a rare shot of excitement. The risks will. Projects are expensive, scaling is tough and timelines are long. Cash burn is real. Any fundraising slows, so does progress. Volatility will. On the NASDAQ ISP shares has swung harder than a Springbok match at Alice Park. The Jaise debut shows just how wild those things can be. In short, exciting Yes, Saif will not necessarily. So what to watch going forward?

6:47 Retail investors should keep an eye on the following cash flow. How fast are they burning through money versus generating revenue? Production milestones How quickly they do the silicon 28 in white terbium? Can they deliver the next isotopes on schedule? Then demand growth is global demand keeping up and can ISP scale to meet it? Local take up?

7:10 Will South African healthcare or energy sectors eventually become customers or is this mostly an export play? Let's do your stock fell starter pack for the JJI ASP edition. Isotopes is dual listed, NASDAQ which is the primary and JSE which is the secondary. The ticker is ISO with 91,000,000 shares. They have 3 facilities in Pretoria and 97% of those staff or South African that already producing silicon 28 and white terbium 176 with more isotopes lined up. NASDAQ brings global liquidity, Jaise brings local access. Now the JSE hype 217 Rand listing price to 1100 and a few days of 400% surge.

7:57 Cried for headlines but don't bet the poori money on short term fireworks. High risk, potentially by reward, could be the future of medicine and energy, or another case of science's heart. And investors lost patience. So while my jokes may be more radioactive than Cuba's maintenance schedule, remember this is not financial advice. Please do your own research. Speak to a licensed advisor.

8:21 This has been Jay. And until next time, get your portfolios diversified and your body rolls properly turned. Otherwise it could end up burning both.

The JSE stories worth knowing about, explained like a mate would at the braai. No hot tips, no spam.

Maze Mail

Subscribe to Maze Mail

Listen to The Money Maze